These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23355534)

  • 1. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.
    Starke RD; Paschalaki KE; Dyer CE; Harrison-Lavoie KJ; Cutler JA; McKinnon TA; Millar CM; Cutler DF; Laffan MA; Randi AM
    Blood; 2013 Apr; 121(14):2773-84. PubMed ID: 23355534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease.
    Wang JW; Bouwens EA; Pintao MC; Voorberg J; Safdar H; Valentijn KM; de Boer HC; Mertens K; Reitsma PH; Eikenboom J
    Blood; 2013 Apr; 121(14):2762-72. PubMed ID: 23426949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
    Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
    Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease.
    Groeneveld DJ; van Bekkum T; Dirven RJ; Wang JW; Voorberg J; Reitsma PH; Eikenboom J
    J Thromb Haemost; 2015 Oct; 13(10):1854-66. PubMed ID: 26270243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation.
    Castaman G; Giacomelli SH; Jacobi PM; Obser T; Budde U; Rodeghiero F; Schneppenheim R; Haberichter SL
    J Thromb Haemost; 2012 May; 10(5):951-8. PubMed ID: 22429825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.
    Bowman ML; Pluthero FG; Tuttle A; Casey L; Li L; Christensen H; Robinson KS; Lillicrap D; Kahr WHA; James P
    J Thromb Haemost; 2017 Jul; 15(7):1403-1411. PubMed ID: 28453889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.
    Hawke L; Bowman ML; Poon MC; Scully MF; Rivard GE; James PD
    Blood; 2016 Jul; 128(4):584-93. PubMed ID: 27317792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular characterization of von Willebrand disease: good in parts.
    James PD; Lillicrap D
    Br J Haematol; 2013 Apr; 161(2):166-76. PubMed ID: 23406206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.
    De Meyer SF; Vanhoorelbeke K; Chuah MK; Pareyn I; Gillijns V; Hebbel RP; Collen D; Deckmyn H; VandenDriessche T
    Blood; 2006 Jun; 107(12):4728-36. PubMed ID: 16478886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor in its native environment.
    Sadler JE
    Blood; 2013 Apr; 121(14):2583-4. PubMed ID: 23557970
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetic basis of von Willebrand disease.
    Goodeve AC
    Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
    Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
    J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.
    Ewenstein BM; Inbal A; Pober JS; Handin RI
    Blood; 1990 Apr; 75(7):1466-72. PubMed ID: 2317558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
    Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
    Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
    Meinkoth JH; Meyers KM
    Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.
    Schillemans M; Karampini E; van den Eshof BL; Gangaev A; Hofman M; van Breevoort D; Meems H; Janssen H; Mulder AA; Jost CR; Escher JC; Adam R; Carter T; Koster AJ; van den Biggelaar M; Voorberg J; Bierings R
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1549-1561. PubMed ID: 29880488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.
    Brehm MA; Huck V; Aponte-Santamaría C; Obser T; Grässle S; Oyen F; Budde U; Schneppenheim S; Baldauf C; Gräter F; Schneider SW; Schneppenheim R
    Thromb Haemost; 2014 Jul; 112(1):96-108. PubMed ID: 24598842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.